Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor

Clinical trial NCT00412061 · COMPLETED

Trial details

NCT number: NCT00412061
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoid Tumor Malignant Carcinoid Syndrome

Start date: 2006-12-01
Primary completion: 2010-04-01
Enrollment: 429

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.